Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Emerging threats demand new approach to disaster preparedness

The SARS epidemic, the South Asian tsunami, Hurricane Katrina, and avian influenza all underline a growing need for preparedness planning that addresses multiple hazards and coordinates all levels of government and society, said a panel of public health experts today at the Pan American Health Organization (PAHO) in Washington, D.C.

3 Apr 2007

President's Emergency Plan for AIDS Relief making significant contributions to the fight against HIV/AIDS pandemic

...but it needs to strengthen its prevention efforts and develop programs that ensure long-term sustainability in focus countries, according to a report released Friday by the Institute of Medicine and the National Research Council, the Washington Post reports

2 Apr 2007

Six centers of excellence for influenza research and surveillance established in U.S.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.

2 Apr 2007

USAID strengthens fight against avian influenza globally

The U.S. Government through the U.S. Agency for International Development (USAID) announced a one- year, $19 million project to provide critical commodities to fight avian influenza.

2 Apr 2007

MedImmune licenses reverse genetics technology to sanofi pasteur

MedImmune has announced that it has licensed its proprietary reverse genetics intellectual property to sanofi pasteur, the vaccines business of the sanofi-aventis Group, to support the development and construction of new vaccine strains to produce human seasonal, pre-pandemic and pandemic influenza vaccines.

1 Apr 2007

Progress towards better access to pandemic influenza vaccines for developing countries

The World Health Organization (WHO) is reporting progress towards ensuring access to pandemic influenza vaccines for developing countries in the event of a pandemic and other vaccine-related aspects of influenza pandemic preparedness.

25 Mar 2007

Microbix granted Canadian patent for vaccine technology

Microbix Biosystems has announced that it has been granted a patent by the Canadian Patent Office for its Vaccine Technology. This technology holds the promise of significantly boosting global production of influenza vaccines.

22 Mar 2007

Flu pandemic could cost U.S. $683 billion

Trust for America's Health (TFAH) released a new report today that finds a severe pandemic flu outbreak could result in the second worst recession in the U.S. since World War II. The U.S. Gross Domestic Product (GDP) could drop over 5.5 percent, leading to an estimated $683 billion loss.

22 Mar 2007

Roche files NDA for pediatric Tamiflu capsules

Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg.

12 Mar 2007

Second bird flu death in Laos - 11th country to fall victim to H5N1

The death of a 15-year-old girl from Laos from the deadly H5N1 strain of bird flu, is the country's first officially confirmed victim of the disease.

11 Mar 2007

PAHO, Canada sign agreement to advance health programs

The Pan American Health Organization and the Government of Canada today signed a four-year agreement to support international health work in the Americas.

8 Mar 2007

China's southern Guangdong Province found to be source of H5N1

A team of scientists at the University of California, Irvine, who have been conducting a genetic analysis of the H5N1 bird flu virus, have found that China's southern Guangdong Province is the source of the deadly strain.

7 Mar 2007

Bird flu vaccine - experts say let's try harder

Experts on viruses are calling for a bigger effort to be made in developing vaccines to tackle pandemics.

6 Mar 2007

Another case of bird flu appears in Laos

World Health Organization (WHO) officials say it is likely 42-year-old woman who died in Laos had bird flu.

4 Mar 2007

Further study of past flu pandemics key to future preparedness

Scientists and public health officials, wary that the H5N1 avian influenza virus could trigger an influenza pandemic, have looked to past pandemics, including the 1918 "Spanish Flu," for insight into pandemic planning.

28 Feb 2007

Bird flu vaccine offers limited protection but 'better than nothing'

Despite evidence it will not protect most people, a panel of health advisers have recommended that the Food and Drug Administration (FDA) in the United States approve the first vaccine against bird flu.

28 Feb 2007

First 3-D structure from key influenza protein revealed

In 1918, 50 million people died during a worldwide influenza pandemic caused by mutation of a bird-specific strain of the influenza virus. Recently H5N1, another highly infectious avian strain has caused outbreaks of bird flu around the world.

27 Feb 2007

Blueprint for influenza pandemic

The American Public Health Association (APHA) today released its blueprint for strengthening the nation's pandemic preparedness, amid persistent concerns about a potential influenza pandemic.

22 Feb 2007

Entire genetic blueprints of more than 2,000 human and avian influenza viruses completed and made public

The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), announced today that it has achieved a major milestone.

21 Feb 2007